These substances are related to the DEA’s interest in researching hallucinogenic controlled products for clinical tests and research. The DEA asserts that it wants to support the regulated trials of schedule 1 substances, so increasing the production quota explains why this move is essential. The DEA also wants to research the requirements for manufacturing new drugs and the kind of impact marijuana has on the body. These steps are taken to work towards the Food and Drug Administration’s possibilities to approve a new drug.
A land-rooted look at the growers reshaping cannabis through living soil, ecological intelligence and regenerative…
Jowell & Randy member Randy is expanding into cannabis with La Zaza, a brand built…
wo of the most popular autoflowering takes on the Cookies family are Auto Girl Scout…
Jamaica has introduced two new special permits designed to help traditional growers and small farmers…
Italy has extensive opioid use, established illicit drug markets and criminal organizations capable of moving…
A strange prophecy sends an isolated artist on a three-day collision with grief, love, creativity,…